Alimta Approved as Maintenance Therapy for Advanced Lung Cancer – US News and World Report
The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.
Published online in Diabetologia, three of the four studies found some type of cancer-related association with the long-acting insulin analog.
I have a link to Diabetologia on my sidebar if you are interested in downloading the original studies.
Colorectal Cancer Rates Rising for Under 50 Set – BusinessWeek
To get a handle on the trends, Siegel and her team reviewed data on about 11,000 men and 9,800 women younger than 50 that was gleaned from 13 U.S. cancer registries that tracked information from 1992 through2005. During this time, the researchers found, colorectal cancer rates increased 1.5 percent a year among men younger than 50 and 1.6 percent
a year among women younger than 50.
This study was funded by GlaxoSmithKline.
The study was conducted by a physician who is a consultant for GlaxoSmithKline.
Newswise Medical News | New Research Finds Six Factors Predictive of Melanoma Risk
The six factors are:
Alarming Numbers For Black Men And Colorectal Cancer : NPR
Yet another post in the periodic Double Cheeseburger series. Pay particular attention to the last two minutes of this podcast for an excellent risk factor summary and recommendations for lifestyle changes. There is a lot of relevant information for assessing risk in this short interview.
lifeunderwriter.net 